Ovarian Cancer Early Detection Screening Program
While survival rates for other women’s cancers – like breast and cervical cancer – have dramatically improved in recent years, the incidence and mortality of ovarian cancer has remained relatively unchanged in the past 50 years.
When caught in its earliest stages, survival rates for ovarian cancer can be as high as 90 percent. Regrettably, however, early symptoms are difficult to diagnose, are often misdiagnosed, or go undetected. This leads to 75% of all ovarian cancer patients being diagnosed in advanced stages when the disease is more difficult to treat. Improvement in clinical early detection is critical to changing these sobering statistics.
The Rivkin Center’s Ovarian Cancer Early Detection Screening Program serves as a model for other programs across the nation serving women determined at high-risk for developing ovarian cancer. The program provides women with the most advanced screening tests currently available, while also providing researchers the tools to identify and discover new techniques to detect ovarian cancer at its earliest stages.